Search results for "phosphodiester"

showing 10 items of 176 documents

Inhibitory activity of sphingomyelin on hemolytic activity of coelomic fluid of Holothuria polii (echinodermata)

1987

Abstract The hemolytic activity of coelomic fluid from Holothuria polii is specifically inhibited by sphingomyelin. This phospholipid is the constituent of the membrane which probably interacts with the hemolysin thereby leading to the lysis.

ErythrocytesLysisSea CucumbersImmunologyPhospholipidSettore BIO/05 - ZoologiaInhibitory postsynaptic potentialHemolysisMicrobiologychemistry.chemical_compoundmedicineAnimalsPhospholipidsComplement Inactivator ProteinsBacteriabiologyHemolysinbiology.organism_classificationBody FluidsSphingomyelinsRed blood cellCholesterolSphingomyelin Phosphodiesterasemedicine.anatomical_structurechemistryBiochemistryCoelomlipids (amino acids peptides and proteins)SphingomyelinHolothuriaEchinodermataDevelopmental Biology
researchProduct

Evidence that clustered phosphocholine head groups serve as sites for binding and assembly of an oligomeric protein pore.

2006

High susceptibility of rabbit erythrocytes toward the pore-forming action of staphylococcal alpha-toxin correlates with the presence of saturable, high affinity binding sites. All efforts to identify a protein or glycolipid receptor have failed, and the fact that liposomes composed solely of phosphatidylcholine are efficiently permeabilized adds to the enigma. A novel concept is advanced here to explain the puzzle. We propose that low affinity binding moieties can assume the role of high affinity binding sites due to their spatial arrangement in the membrane. Evidence is presented that phosphocholine head groups of sphingomyelin, clustered in sphingomyelin-cholesterol microdomains, serve th…

ErythrocytesPhosphorylcholineBacterial ToxinsBiologyBiochemistryCell Linechemistry.chemical_compoundHemolysin ProteinsGlycolipidMembrane MicrodomainsPhosphatidylcholineAnimalsHumansReceptorProtein Structure QuaternaryMolecular BiologyPhosphocholineLiposomeBinding SitesCell BiologySphingomyelinsMembraneCholesterolSphingomyelin PhosphodiesteraseBiochemistrychemistryLiposomesRabbitsSphingomyelinFunction (biology)Protein BindingThe Journal of biological chemistry
researchProduct

Homologies Between Different Forms of 2-5A Synthetases

1994

(2′-5′) Oligoadenylate synthetases (2-5A synthetases; EC 2.7.7.19) are present in mammalian cells and tissues and synthesize from ATP a series of oligomers termed 2-5A [general formula: ppp(A2′p)nA; with 1 ≤ n < 18 and usually 1 ≤ n < 6] (Hovanessian 1991). For full enzymic activity of the 2-5A synthetases, binding of double-stranded RNA is required (Sen 1982). Three principal 2-5A synthetase isoenzymes have been described with Mr’s of 40–46, 69, and 100 kDa (Chebath et al. 1987; Hovanessian et al. 1987, 1988). In the following they are classified as 2-5A synthetase I [Mr 40–46 000], II [Mr 69 000] and III [Mr 100 000]. All three isoforms are induced in cells by interferon (Cohen et al. 198…

Gene isoformActivator (genetics)EndoribonucleaseMicrosomePhosphodiesteraseRNABinding siteBiologyIsozymeMolecular biology
researchProduct

Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca 2+ sources

2001

We have examined the cyclic nucleotide phosphodiesterase isoforms (PDE) involved in the contractile response of rat aorta to different agonists and different experimental procedures for use in functional studies. The inhibitory effect of AAL 05 on the different PDEs isolated from bovine aortic smooth muscle was examined. Compound AAL 05 appeared to be a selective PDE3 inhibitor. We analyzed the ability of the non-selective inhibitor IBMX (3-isobutyl-1-methylxanthine) and the isoenzyme selective inhibitors nimodipine (type 1), AAL 05 (6-(N-methyl-N-cyclohexyl butyl carboxamide) quinolin-2-one) and SKF 94120 (5-(4-acetamidophenyl) pyrazin-2(1H)-one; type3), rolipram (type4) and zaprinast (typ…

Gene isoformPurinonesPhosphodiesterase InhibitorsPhosphodiesterase 3BiologyIsozymeMuscle Smooth Vascular1-Methyl-3-isobutylxanthinemedicine.arterymedicineAnimalsFunctional studiesRats WistarInhibitory effectAortaPharmacologyAortaCyclic nucleotide phosphodiesteraseContractile responseGeneral MedicineRatsIsoenzymesBiochemistryVasoconstrictionCalcium2'3'-Cyclic-Nucleotide PhosphodiesterasesRolipramNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity.

2013

Cell death in response to oxidative stress plays a role in a variety of neurodegenerative diseases and can be studied in detail in the neuronal cell line HT22, where extracellular glutamate causes glutathione depletion by inhibition of the glutamate/cystine antiporter system xc(-), elevation of reactive oxygen species and eventually programmed cell death caused by cytotoxic calcium influx. Using this paradigm, we screened 54 putative extracellular peptide or small molecule ligands for effects on cell death and identified extracellular cyclic guanosine monophosphate (cGMP) as a protective substance. Extracellular cGMP was protective, whereas the cell-permeable cGMP analog 8-pCPT-cGMP or the …

GuanosineGlutamic AcidBiologymedicine.disease_causeReal-Time Polymerase Chain ReactionNeuroprotectionCell LineCellular and Molecular Neurosciencechemistry.chemical_compoundMiceExtracellularmedicineAnimalsPhosphorylationCyclic guanosine monophosphateCyclic GMPGuanosineGlutamate receptorPhosphodiesteraseCell BiologyGlutathioneOxidative StressBiochemistrychemistryCalciumExtracellular SpaceProtein KinasesOxidative stressNeurochemistry international
researchProduct

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations

1999

Several reports indicate that aprotinin treatment before and during cardiopulmonary bypass (CPB) might have a protective effect on the myocardium. We evaluated the hemodynamic effects of perioperative aprotinin treatment.We conducted a randomized, double-blind, placebo-controlled trial in 34 infants (mean age, 2.5 years) who had cardiac operations. Half of the patients received high-dose aprotinin therapy. There were no significant differences between the aprotinin and placebo groups with respect to age, weight, sex, aortic cross-clamp time, and CPB time. The following data were recorded at arrival in the intensive care unit 6, 12, 24, and 48 hours after termination of CPB: heart rate, bloo…

Heart Defects CongenitalMalePulmonary and Respiratory MedicineAdolescentPhosphodiesterase InhibitorsHemodynamicsPlaceboHemostaticslaw.inventionAprotininDouble-Blind MethodlawHeart rateCardiopulmonary bypassHumansMedicineEnoximoneAprotininChildEnoximoneCardiopulmonary Bypassbusiness.industryHemodynamicsInfant NewbornInfantFurosemideBlood pressureChild PreschoolAnesthesiaFemaleSurgeryCardiology and Cardiovascular Medicinebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugThe Annals of Thoracic Surgery
researchProduct

Synergistic Platelet Inhibitory Effect of the Phosphodiesterase Inhibitor Piroximone and Iloprost

1992

Platelet activity is regulated through synthesis and degradation of the intracellular second messengers cAMP or cGMP. The antiplatelet effect of the phosphodiesterase (PDE) III inhibitor Piroximone (PIR) was studied in vitro in platelet rich plasma. ADP induced aggregation was inhibited by PIR with an IC50 of 67 +/- 43 microM. The inhibitory effect was time and dose dependent. The antiaggregatory effects in vivo were studied in anaesthetised rats. Reduction of platelet count following injection of 100 micrograms/kg bw collagen was measured after bolus injection of PIR and vehicle. Piroximone bolus 2 mg/kg bw resulted in a 50% inhibition of platelet aggregation in rats. Cyclic AMP levels in …

In vivoChemistrymedicinePhosphodiesterasePlatelet aggregation inhibitorProstacyclinPlateletPlatelet activationPhosphodiesterase inhibitorPharmacologyIloprostmedicine.drug
researchProduct

Response of soil phosphatase activities to contamination with two types of tar oil.

2018

Tar oil is a complex mixture of hydrocarbon compounds obtained from high-temperature distillation of coal tar. It has been used for over 100 years from now to protect wood and has been applied to wood products, primary utility poles, and railroad ties by pressure methods. Composition of the tar oil depends on the source and typically consists of 85% polycyclic aromatic hydrocarbons (PAHs), 10% phenolic compounds, and 5% heterocyclic compounds. In this research, we performed the laboratory experiment to compare two types of tar oil: C and GX-Plus, and their effects on P-cycling enzymes (phosphatases) in sandy loam and loamy sand. Tar oil was applied to soil samples at the following doses: 2,…

Inorganic pyrophosphataseSoil testvirusesHealth Toxicology and Mutagenesis010501 environmental sciencescomplex mixtures01 natural scienceslaw.inventionSoilPAHslawotorhinolaryngologic diseasesmedicineEnvironmental ChemistrySoil PollutantsPhosphodiesteraseCoal tarPolycyclic Aromatic HydrocarbonsDistillationCoal Tar0105 earth and related environmental scienceschemistry.chemical_classificationLoamy sandTar04 agricultural and veterinary sciencesGeneral MedicineContaminationPollutionHydrocarbonsPhosphoric Monoester HydrolasesHydrocarbonchemistryPhosphomonoesterasesEnvironmental chemistryLoamPhosphotriesterase040103 agronomy & agriculture0401 agriculture forestry and fisheriesComposition (visual arts)Sandy loamPolandResistance indexmedicine.drugEnvironmental science and pollution research international
researchProduct

Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.

1992

The phosphodiesterase inhibitors have been recognised as potent inotropic and vasodilating drugs. In acute congestive heart failure they increase cardiac output, decrease left pulmonary capillary wedge pressure, and reduce total peripheral resistance with an improvement in loading conditions of the failing heart. Their potency in reversal of symptoms of acute congestive heart failure is quite similar to, or even better than, treatment with intravenous catecholamines and sodium nitroprusside. In chronic congestive heart failure, however, these agents increase mortality and have deleterious effects in the outcome of patients with severe left ventricular dysfunction.

InotropeHeart Failuremedicine.medical_specialtybusiness.industryPhosphodiesterase InhibitorsVasodilationmedicine.diseaseCardiovascular SystemAmrinoneEndocrinologyPimobendanInternal medicineHeart failureAcute DiseaseChronic DiseasemedicineCardiologyMilrinoneEnoximoneHumansPharmacology (medical)Pulmonary wedge pressurebusinessmedicine.drugDrugs
researchProduct

Papaverine enhances the negative inotropic effect of acetylcholine in rat auricles

1978

The negative inotropic effect of acetylcholine in rat left auricles is enhanced in the presence of the phosphodiesterase inhibitor papaverine. This result favours the idea of a cyclic GMP-mediated action of acetylcholine in the heart.

Inotropemedicine.medical_specialtyAction PotentialsIn Vitro TechniquesCellular and Molecular NeurosciencePapaverineInternal medicinemedicineAnimalsHeart AtriaPhosphodiesterase inhibitorCyclic GMPMolecular BiologyPharmacologyPapaverineChemistryPhosphodiesteraseDrug SynergismCell BiologyMyocardial ContractionAcetylcholineRatsEndocrinologyDepression ChemicalMolecular MedicineAcetylcholinemedicine.drugExperientia
researchProduct